Ambu A/S (AMBBY)
- Previous Close
15.85 - Open
16.08 - Bid --
- Ask --
- Day's Range
16.08 - 16.08 - 52 Week Range
9.45 - 17.48 - Volume
900 - Avg. Volume
179 - Market Cap (intraday)
4.282B - Beta (5Y Monthly) 0.87
- PE Ratio (TTM)
123.69 - EPS (TTM)
0.13 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 15, 2021
- 1y Target Est
--
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.
www.ambu.comRecent News: AMBBY
Performance Overview: AMBBY
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMBBY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMBBY
Valuation Measures
Market Cap
4.23B
Enterprise Value
4.28B
Trailing P/E
124.55
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.07
Price/Book (mrq)
5.51
Enterprise Value/Revenue
0.88
Enterprise Value/EBITDA
6.22
Financial Highlights
Profitability and Income Statement
Profit Margin
4.86%
Return on Assets (ttm)
3.25%
Return on Equity (ttm)
4.99%
Revenue (ttm)
4.9B
Net Income Avi to Common (ttm)
238M
Diluted EPS (ttm)
0.13
Balance Sheet and Cash Flow
Total Cash (mrq)
277M
Total Debt/Equity (mrq)
11.59%
Levered Free Cash Flow (ttm)
480.5M
Company Insights: AMBBY
AMBBY does not have Company Insights